Documents & Downloads

BTB01303

Glutamate Release Inhibitor

BTB01303 is a glutamate release inhibitor that targets the excessive release of glutamate from cancer cells. This elevated glutamate level disrupts normal bone turnover and is associated with cancer-induced bone pain. BTB01303 shows potential in alleviating the pain associated with cancer progression, making it a valuable tool for research in cancer and bone biology.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	652129-89-0
Applications	Glutamate Release Inhibitor
Formula	C₁₅H₁₁Cl₂NO₃
Molecular Weight	324.16
SMILES	ClC1=CC(/C=N/C2=CC=C3OCOCC3=C2)=C(O)C(Cl)=C1

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.